메뉴 건너뛰기




Volumn 9, Issue 3, 2012, Pages 170-178

Guidance for the diagnosis, prevention and therapy of osteoporosis in Italy

Author keywords

DEXA; Fractures; Guidelines; Male osteoporosis; Risk factors; Secondary osteoporosis

Indexed keywords

ALENDRONIC ACID; BAZEDOXIFENE; CALCIUM; CLODRONIC ACID; DENOSUMAB; ETIDRONIC ACID; IBANDRONIC ACID; PARATHYROID HORMONE DERIVATIVE; RALOXIFENE; RISEDRONIC ACID; STRONTIUM RANELATE; VITAMIN D; ZOLEDRONIC ACID;

EID: 84871886881     PISSN: 17248914     EISSN: 19713266     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (13)

References (45)
  • 1
    • 80052389559 scopus 로고    scopus 로고
    • Systems-based approaches to osteoporosis and fracture care: Policy and research recommendations from the workgroups
    • Adler RA, Bates DW, Dell RM, et al. Systems-based approaches to osteoporosis and fracture care: policy and research recommendations from the workgroups. Osteoporos Int 2011;22 Suppl 3:495-500.
    • (2011) Osteoporos Int , vol.22 , Issue.SUPPL. 3 , pp. 495-500
    • Adler, R.A.1    Bates, D.W.2    Dell, R.M.3
  • 2
    • 75749114795 scopus 로고    scopus 로고
    • Guidelines for the diagnosis, prevention and treatment of osteoporosis. Società Italiana dell'Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro
    • Adami S, Bertoldo F, Brandi ML, et al. Guidelines for the diagnosis, prevention and treatment of osteoporosis. Società Italiana dell'Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro. Reumatismo 2009;61:260-284.
    • (2009) Reumatismo , vol.61 , pp. 260-284
    • Adami, S.1    Bertoldo, F.2    Brandi, M.L.3
  • 3
    • 79952394479 scopus 로고    scopus 로고
    • American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: Executive summary of recommendations
    • Watts NB, Bilezikian JP, Camacho PM, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations. Endocr Pract 2010;16:1016-1019.
    • (2010) Endocr Pract , vol.16 , pp. 1016-1019
    • Watts, N.B.1    Bilezikian, J.P.2    Camacho, P.M.3
  • 4
    • 77956403362 scopus 로고    scopus 로고
    • Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: A consensus document by the Belgian Bone Club
    • Body JJ, Bergmann P, Boonen S, et al. Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. Osteoporos Int 2010;21:1657-1680.
    • (2010) Osteoporos Int , vol.21 , pp. 1657-1680
    • Body, J.J.1    Bergmann, P.2    Boonen, S.3
  • 5
    • 77958163996 scopus 로고    scopus 로고
    • Guidelines on the Diagnosis of Osteoporosis and Assessment of Fracture Risk in Poland of III Central European Congress on Osteoporosis and Osteoarthritis, XV Congress of the Polish Osteoarthrology Society and Polish Foundation of Osteoporosis
    • Czerwiński E, Badurski J, Lorenc R, Osieleniec J. Guidelines on the Diagnosis of Osteoporosis and Assessment of Fracture Risk in Poland of III Central European Congress on Osteoporosis and Osteoarthritis, XV Congress of the Polish Osteoarthrology Society and Polish Foundation of Osteoporosis. Ortop Traumatol Rehabil 2010;12:194-200.
    • (2010) Ortop Traumatol Rehabil , vol.12 , pp. 194-200
    • Czerwiński, E.1    Badurski, J.2    Lorenc, R.3    Osieleniec, J.4
  • 6
    • 78649680817 scopus 로고    scopus 로고
    • Scientific Advisory Council of Osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: Summary
    • Papaioannou A, Morin S, Cheung AM, et al. Scientific Advisory Council of Osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010;182:1864-1873.
    • (2010) CMAJ , vol.182 , pp. 1864-1873
    • Papaioannou, A.1    Morin, S.2    Cheung, A.M.3
  • 7
    • 80054815118 scopus 로고    scopus 로고
    • Scientific Advisory Council of Osteoporosis Canada. Osteoporosis Canada 2010 guidelines for the assessment of fracture risk
    • Lentle B, Cheung AM, Hanley DA, et al. Scientific Advisory Council of Osteoporosis Canada. Osteoporosis Canada 2010 guidelines for the assessment of fracture risk. Can Assoc Radiol J 2011;62:243-250.
    • (2011) Can Assoc Radiol J , vol.62 , pp. 243-250
    • Lentle, B.1    Cheung, A.M.2    Hanley, D.A.3
  • 8
    • 84155164844 scopus 로고    scopus 로고
    • Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists
    • Heberlein I, Demary W, Bloching H, et al. Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists. Z Rheumatol 2011;70:592-601.
    • (2011) Z Rheumatol , vol.70 , pp. 592-601
    • Heberlein, I.1    Demary, W.2    Bloching, H.3
  • 9
    • 84857809428 scopus 로고    scopus 로고
    • 2011 guidelines for the diagnosis and treatment of osteoporosis in Greece
    • Greek National Medicine Agency
    • Makras P, Vaiopoulos G, Lyritis GP; Greek National Medicine Agency. 2011 guidelines for the diagnosis and treatment of osteoporosis in Greece. J Musculoskelet Neuronal Interact 2012;12:38-42.
    • (2012) J Musculoskelet Neuronal Interact , vol.12 , pp. 38-42
    • Makras, P.1    Vaiopoulos, G.2    Lyritis, G.P.3
  • 10
    • 84860549582 scopus 로고    scopus 로고
    • 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis
    • Briot K, Cortet B, Thomas T, et al. 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine 2012;79:304-313.
    • (2012) Joint Bone Spine , vol.79 , pp. 304-313
    • Briot, K.1    Cortet, B.2    Thomas, T.3
  • 11
    • 83555176125 scopus 로고    scopus 로고
    • 2011 Up-date of the consensus statement of the Spanish Society of Rheumatology on osteoporosis
    • Spanish Society of Rheumatology
    • Pérez Edo L, Alonso Ruiz A, Roig Vilaseca D, et al. Spanish Society of Rheumatology. 2011 Up-date of the consensus statement of the Spanish Society of Rheumatology on osteoporosis. Reumatol Clin 2011;7:357-379.
    • (2011) Reumatol Clin , vol.7 , pp. 357-379
    • Pérez Edo, L.1    Alonso Ruiz, A.2    Roig Vilaseca, D.3
  • 12
    • 84858293764 scopus 로고    scopus 로고
    • Clinical practice guidelines for evaluation and treatment of osteoporosis associated to endocrine and nutritional conditions
    • Grupo de Metabolismo Mineral de la Sociedad Española de Endocrinología y Nutrición. Bone Metabolism Working Group of the Spanish Society of Endocrinology
    • Reyes García R, Jódar Gimeno E, García Martín A, et al. Grupo de Metabolismo Mineral de la Sociedad Española de Endocrinología y Nutrición. Clinical practice guidelines for evaluation and treatment of osteoporosis associated to endocrine and nutritional conditions. Bone Metabolism Working Group of the Spanish Society of Endocrinology. Endocrinol Nutr 2012;59:174-196.
    • (2012) Endocrinol Nutr , vol.59 , pp. 174-196
    • Reyes García, R.1    Jódar Gimeno, E.2    García Martín, A.3
  • 13
    • 79961150763 scopus 로고    scopus 로고
    • Consensus statements on osteoporosis diagnosis, prevention, and management in the Philippines
    • Osteoporosis Society of Philippines Foundation, Inc. (OSPFI); Philippine Orthopedic Association (POA) Clinical Practice Guidelines Task Force Committee on Osteoporosis
    • Li-Yu J, Perez EC, Cañete A, et al. Osteoporosis Society of Philippines Foundation, Inc. (OSPFI); Philippine Orthopedic Association (POA) Clinical Practice Guidelines Task Force Committee on Osteoporosis. Consensus statements on osteoporosis diagnosis, prevention, and management in the Philippines. Int J Rheum Dis 2011;14:223-238.
    • (2011) Int J Rheum Dis , vol.14 , pp. 223-238
    • Li-Yu, J.1    Perez, E.C.2    Cañete, A.3
  • 14
    • 84864875473 scopus 로고    scopus 로고
    • Risk assessment of fragility fractures: Summary of NICE guidance
    • Guideline Development Group. Aug 8
    • Rabar S, Lau R, O'Flynn N, et al. Guideline Development Group. Risk assessment of fragility fractures: summary of NICE guidance. BMJ 2012 Aug 8;345:e3698.
    • (2012) BMJ , vol.345
    • Rabar, S.1    Lau, R.2    O'Flynn, N.3
  • 15
    • 84872285060 scopus 로고    scopus 로고
    • European guidance for the diagnosis and management of osteoporosis in postmenopausal women
    • on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). Oct 19. [Epub ahead of print]
    • Kanis JA, McCloskey EV, Johansson H, et al. on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2012 Oct 19. [Epub ahead of print].
    • (2012) Osteoporos Int
    • Kanis, J.A.1    McCloskey, E.V.2    Johansson, H.3
  • 16
    • 84876286264 scopus 로고    scopus 로고
    • Japanese 2011 guidelines for prevention and treatment of osteoporosis-executive summary
    • Orimo H, Nakamura T, Hosoi T, et al. Japanese 2011 guidelines for prevention and treatment of osteoporosis-executive summary. Arch Osteoporos 2012.
    • (2012) Arch Osteoporos
    • Orimo, H.1    Nakamura, T.2    Hosoi, T.3
  • 17
    • 84861973260 scopus 로고    scopus 로고
    • Endocrine Society. Osteoporosis in men: An Endocrine Society clinical practice guideline
    • Watts NB, Adler RA, Bilezikian JP et al. Endocrine Society. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012;97:1802-1822.
    • (2012) J Clin Endocrinol Metab , vol.97 , pp. 1802-1822
    • Watts, N.B.1    Adler, R.A.2    Bilezikian, J.P.3
  • 18
    • 79951581065 scopus 로고    scopus 로고
    • American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
    • Hoboken
    • Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 2010;62:1515-1526.
    • (2010) Arthritis Care Res , vol.62 , pp. 1515-1526
    • Grossman, J.M.1    Gordon, R.2    Ranganath, V.K.3
  • 19
    • 84867098592 scopus 로고    scopus 로고
    • A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
    • Joint IOF-ECTS GIO Guidelines Working Group
    • Lekamwasam S, Adachi JD, Agnusdei D, et al. Joint IOF-ECTS GIO Guidelines Working Group. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 2012;23:2257-2276.
    • (2012) Osteoporos Int , vol.23 , pp. 2257-2276
    • Lekamwasam, S.1    Adachi, J.D.2    Agnusdei, D.3
  • 20
    • 84866492201 scopus 로고    scopus 로고
    • Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis
    • Pereira RM, Carvalho JF, Paula AP, et al. Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis. Rev Bras Reumatol 2012;52:580-593.
    • (2012) Rev Bras Reumatol , vol.52 , pp. 580-593
    • Pereira, R.M.1    Carvalho, J.F.2    Paula, A.P.3
  • 21
    • 84863718113 scopus 로고    scopus 로고
    • Recommendations for antiresorptive therapy in postmenopausal patients with breast cancer: Marburg AIBL Guideline Evaluation Study (MAGES)
    • Hadji P, Hartenfels M, Kyvernitakis J, et al. Recommendations for antiresorptive therapy in postmenopausal patients with breast cancer: Marburg AIBL Guideline Evaluation Study (MAGES). Breast Cancer Res Treat 2012;133:1089-1096.
    • (2012) Breast Cancer Res Treat , vol.133 , pp. 1089-1096
    • Hadji, P.1    Hartenfels, M.2    Kyvernitakis, J.3
  • 22
    • 84868193373 scopus 로고    scopus 로고
    • On behalf of the European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO). Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: An ESCEO position paper
    • Rizzoli R, Body JJ, De Censi A, et al. on behalf of the European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO). Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper. Osteoporos Int 2012;23:2567-2576.
    • (2012) Osteoporos Int , vol.23 , pp. 2567-2576
    • Rizzoli, R.1    Body, J.J.2    De Censi, A.3
  • 23
    • 79952230364 scopus 로고    scopus 로고
    • Screening for osteoporosis: U.S. preventive services task force recommendation statement
    • U.S. Preventive Services Task Force
    • U.S. Preventive Services Task Force. Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med 2011;154:356-364.
    • (2011) Ann Intern Med , vol.154 , pp. 356-364
  • 24
    • 84855758588 scopus 로고    scopus 로고
    • Adherence to the U.S. Preventive Services Task Force 2002 osteoporosis screening guidelines in academic primary care settings
    • Larchmt
    • Powell H, O'Connor K, Greenberg D. Adherence to the U.S. Preventive Services Task Force 2002 osteoporosis screening guidelines in academic primary care settings. J Womens Health (Larchmt) 2012;21:50-53.
    • (2012) J Womens Health , vol.21 , pp. 50-53
    • Powell, H.1    O'Connor, K.2    Greenberg, D.3
  • 25
    • 84857439516 scopus 로고    scopus 로고
    • The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: An update in NHANES 2005-2008
    • Mar
    • Dawson-Hughes B, Looker AC, Tosteson AN, et al. The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008. Osteoporos Int 2012 Mar;23(3):811-20.
    • (2012) Osteoporos Int , vol.23 , Issue.3 , pp. 811-820
    • Dawson-Hughes, B.1    Looker, A.C.2    Tosteson, A.N.3
  • 26
    • 84869768551 scopus 로고    scopus 로고
    • Use of bone turnover markers in clinical practice
    • Biver E. Use of bone turnover markers in clinical practice. Curr Opin Endocrinol Diabetes Obes 2012;19:468-473.
    • (2012) Curr Opin Endocrinol Diabetes Obes , vol.19 , pp. 468-473
    • Biver, E.1
  • 27
    • 77954171802 scopus 로고    scopus 로고
    • Dual X-ray absorptiometry in today's clinical practice
    • Dasher LG, Newton CD, Lenchik L. Dual X-ray absorptiometry in today's clinical practice. Radiol Clin North Am 2010;48:541-560.
    • (2010) Radiol Clin North Am , vol.48 , pp. 541-560
    • Dasher, L.G.1    Newton, C.D.2    Lenchik, L.3
  • 28
    • 77954169429 scopus 로고    scopus 로고
    • Quantitative computed tomography
    • Lang TF. Quantitative computed tomography. Radiol Clin North Am 2010;48:589-600.
    • (2010) Radiol Clin North Am , vol.48 , pp. 589-600
    • Lang, T.F.1
  • 29
    • 77954168705 scopus 로고    scopus 로고
    • Quantitative ultrasound in osteoporosis and bone metabolism pathologies
    • Guglielmi G, Scalzo G, de Terlizzi F, Peh WC. Quantitative ultrasound in osteoporosis and bone metabolism pathologies. Radiol Clin North Am 2010;48:577-588.
    • (2010) Radiol Clin North Am , vol.48 , pp. 577-588
    • Guglielmi, G.1    Scalzo, G.2    De Terlizzi, F.3    Peh, W.C.4
  • 31
    • 43049175471 scopus 로고    scopus 로고
    • FRAX and the assessment of fracture probability in men and women from the UK
    • Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385-397.
    • (2008) Osteoporos Int , vol.19 , pp. 385-397
    • Kanis, J.A.1    Johnell, O.2    Oden, A.3
  • 32
    • 79960904776 scopus 로고    scopus 로고
    • Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice
    • FRAX(®) Position Development Conference Members. Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Jul-Sep
    • Hans DB, Kanis JA, Baim S, et al. FRAX(®) Position Development Conference Members. Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice. J Clin Densitom 2011 Jul-Sep;14(3):171-80.
    • (2011) J Clin Densitom , vol.14 , Issue.3 , pp. 171-180
    • Hans, D.B.1    Kanis, J.A.2    Baim, S.3
  • 34
    • 78650822592 scopus 로고    scopus 로고
    • Antifracture efficacy of currently available therapies for postmenopausal osteoporosis
    • Reginster JY. Antifracture efficacy of currently available therapies for postmenopausal osteoporosis. Drugs 2011;71:65-78.
    • (2011) Drugs , vol.71 , pp. 65-78
    • Reginster, J.Y.1
  • 35
    • 77958139463 scopus 로고    scopus 로고
    • Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis
    • Brandi ML. Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis. Curr Med Res Opin 2010;26:2553-2563.
    • (2010) Curr Med Res Opin , vol.26 , pp. 2553-2563
    • Brandi, M.L.1
  • 36
    • 84871891818 scopus 로고    scopus 로고
    • Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
    • Nov 20. [Epub ahead of print]
    • McClung M, Harris ST, Miller PD, et al. Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday. Am J Med 2012 Nov 20. [Epub ahead of print].
    • (2012) Am J Med
    • McClung, M.1    Harris, S.T.2    Miller, P.D.3
  • 37
    • 82055162846 scopus 로고    scopus 로고
    • Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: Executive summary of recommendations from the American Dental Association Council on Scientific Affairs
    • American Dental Association Council on Scientific Affairs Expert Panel on Antiresorptive Agents. Nov
    • Hellstein JW, Adler RA, Edwards B, et al. American Dental Association Council on Scientific Affairs Expert Panel on Antiresorptive Agents. Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 2011 Nov;142(11):1243-51.
    • (2011) J Am Dent Assoc , vol.142 , Issue.11 , pp. 1243-1251
    • Hellstein, J.W.1    Adler, R.A.2    Edwards, B.3
  • 38
    • 84857508749 scopus 로고    scopus 로고
    • The 2012 hormone therapy position statement of: The North American Menopause Society
    • North American Menopause Society
    • North American Menopause Society. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause 2012;19:257-271.
    • (2012) Menopause , vol.19 , pp. 257-271
  • 39
    • 33750118602 scopus 로고    scopus 로고
    • Secondary osteoporosis: A review of the recent evidence
    • Painter SE, Kleerekoper M, Camacho PM. Secondary osteoporosis: a review of the recent evidence. Endocr Pract 2006 Jul-Aug;12(4):436-45. (Pubitemid 44717606)
    • (2006) Endocrine Practice , vol.12 , Issue.4 , pp. 436-445
    • Painter, S.E.1    Kleerekoper, M.2    Camacho, P.M.3
  • 41
    • 84866005612 scopus 로고    scopus 로고
    • Management of glucocorticoid-induced osteoporosis
    • Rizzoli R, Adachi JD, Cooper C, et al. Management of glucocorticoid- induced osteoporosis. Calcif Tissue Int 2012;91:225-243.
    • (2012) Calcif Tissue Int , vol.91 , pp. 225-243
    • Rizzoli, R.1    Adachi, J.D.2    Cooper, C.3
  • 42
    • 59749085382 scopus 로고    scopus 로고
    • Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the third international workshop
    • Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism
    • Bilezikian JP, Khan AA, Potts JT Jr. Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009;94:335-339.
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 335-339
    • Bilezikian, J.P.1    Khan, A.A.2    Potts Jr., J.T.3
  • 44
    • 84867868892 scopus 로고    scopus 로고
    • Bone disease in organ transplant patients: Pathogenesis and management
    • Chauhan V, Ranganna KM, Chauhan N, et al. Bone disease in organ transplant patients: pathogenesis and management. Postgrad Med 2012;124:80-90.
    • (2012) Postgrad Med , vol.124 , pp. 80-90
    • Chauhan, V.1    Ranganna, K.M.2    Chauhan, N.3
  • 45
    • 70349383181 scopus 로고    scopus 로고
    • Neridronic acid for the treatment of bone metabolic diseases
    • Gatti D, Viapiana O, Idolazzi L, et al. Neridronic acid for the treatment of bone metabolic diseases. Expert Opin Drug Metab Toxicol 2009;5:1305-1311.
    • (2009) Expert Opin Drug Metab Toxicol , vol.5 , pp. 1305-1311
    • Gatti, D.1    Viapiana, O.2    Idolazzi, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.